FDA Alert: Baxter Recalls Spectrum Infusion Pumps

Baxter Spectrum Infusion Pump Alert

Date: July 2025
Device: Sigma Spectrum Infusion System (V6 and V8 Platforms)
Manufacturer: Baxter Healthcare
Issue Type: Urgent Medical Device Recall
FDA Status: High-risk; active monitoring in progress

The FDA has issued an early alert regarding a critical safety issue with certain Baxter Spectrum infusion pumps that may have incorrect software versions installed. The problem affects both the V6 and V8 models of the Sigma Spectrum Infusion System.

What’s the Risk?

Some V6 pumps were loaded with V8 software, and vice versa. This mismatch can:

• Cause inaccurate infusion flow rates (underinfusion or overinfusion).
• Lead to user confusion due to differences in menus and clinical workflow.
• Result in serious health consequences such as:
• Drug toxicity or overdose
• Fluid overload
• Electrolyte imbalances
• Delayed or ineffective therapy
• In extreme cases, injury or death

As of June 12, no injuries or deaths have been reported.

What You Should Do

1. Identify and Remove: Locate pumps with affected serial numbers and remove them from service immediately.
2. Check Software Versions: Verify the software version on the startup screen or using the pump menu (V6 versions should start with “6”, and V8 with “8”).
3. Contact Baxter:
• Call 800-843-7867 (Mon–Fri, 7:00 AM to 7:00 PM ET).
• Or email corporate_product_complaints_round_lake@baxter.com
4. Acknowledge Notice: If you received Baxter’s communication directly, confirm receipt to avoid follow-up calls.
5. Notify Clinical Staff: Forward this alert to your facility’s pharmacy, nursing, risk management, and supply chain leadership.
6. Distributors: Notify downstream customers per your procedures.

Why This Matters

The software discrepancy may not be immediately obvious, but it poses a significant risk of dosing errors, especially during long infusion periods or in high-risk patients. Immediate identification and correction are critical to prevent harm.

The FDA is actively reviewing the situation and will update the public as new information becomes available.

Stay informed. Stay safe.

Read more about the FDA Alert here.

For the latest updates and more information, visit the FDA’s official website or report concerns through the MedWatch Adverse Event Reporting Program.